Investors

Home / Investors / Events

Upcoming Events

There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.

 

Past Events

Mar 16 2023 4:30pm ET

Fourth Quarter and Full Year 2022 Financial Results Conference Call

March 16, 2023 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID # 13736281.

Mar 13 2023 11:20 am ET

Oppenheimer 33rd Annual Healthcare Conference

March 13, 2023 at 11:20 am ET

Feb 15 2023 3:40 PM ET

SVB Securities Global Biopharma Conference

February 15, 2023 at 3:40 PM ET

Dec 1 2022 10:30 am ET

34th Annual Piper Sandler Healthcare Conference

December 1, 2022 at 10:30 am ET

Nov 14 2022 4:30 pm ET

Third Quarter 2022 Financial Results Conference Call

November 14, 2022 at 4:30 pm ET

To access the live conference call, please dial 855-327-6837 from the U.S. and Canada, or 631-891-4304 internationally, Conference ID #10020554.

Nov 8 2022 1:25 pm PT

Credit Suisse 31st Healthcare Conference

November 8, 2022 at 1:25 pm PT

Nov 4 2022

The Liver Meeting® 2022

November 4 - November 8, 2022

Washington, DC

Sep 22 2022 10:30am ET

Virtual Analyst Day

September 22, 2022 at 10:30am ET

Sep 14 2022 11:30am ET

H.C. Wainwright 24th Annual Global Investment Conference

September 14, 2022 at 11:30am ET

Aug 24 2022 12:00pm ET

B. Riley Securities PBC Mini Symposium

August 24, 2022 at 12:00pm ET

Aug 11 2022 4:30pm ET

Second Quarter 2022 Financial Results Conference Call

August 11, 2022 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID#13730902.

Jun 22 2022

The International Liver Congress™ 2022

June 22 - June 25, 2022

London, UK

June 23rd 9:00 – 18:30 BST
1529:
1“Seladelpar Treatment of Patients With Primary Biliary Cholangitis (PBC) For 2 Years Improves the GLOBE PBC Score and Predicts Improved Transplant-Free Survival”

Bettina E. Hansen, Elaine Watkins, Ke Yang, Yun-Jung Choi, Charles A. McWherter, Gideon M. Hirschfield, for the Seladelpar Long-Term Study Investigators

June 24th 9:00 – 18:00 BST
1518:
2Comparative fibrosis-reducing activities of farnesoid X receptor (FXR), peroxisome-proliferator activated receptor delta (PPAR) and thyroid hormone receptor (THR) agonists in the carbon tetrachloride mouse model
Edward Cable, Jeffrey Stebbins, Yun-Jung Choi, Jiangao Song, Prasad Manchem, Sanjay Pandey, Charles A. McWherter

Oral Presentation:

June 25th 9:00 AM BST
2726:
3“The selective PPAR-delta agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 through the FGF21 pathway
Tetsuya Kouno, Xiao Liu, Tatiana Kisseleva, Edward E. Cable, Bernd Schnabl

Congress attendees can visit CymaBay throughout the meeting at booth 93.

A full list of presentations can be found on The International Liver Congress ™ 2022 website.

Jun 9 2022 8:00am PT

Annual Meeting of Stockholders

June 9, 2022 at 8:00am PT

May 22 2022

DDW Presidential Plenary Presentation

May 22, 2022

May 22nd 8:00 AM PDT
323:
1“Seladelpar Treatment of Patients With Primary Biliary Cholangitis (PBC) For 2 Years Improves the GLOBE PBC Score and Predicts Improved Transplant-Free Survival”
Bettina E. Hansen, Elaine Watkins, Ke Yang, Yun-Jung Choi, Charles A. McWherter, Gideon M. Hirschfield,
for the Seladelpar Long-Term Study Investigators

Clinical Poster Presentations:
May 22nd 12:30 PM PDT
1348:
2“Efficacy, Safety, and Tolerability of Seladelpar in Patients With Compensated Liver Cirrhosis Due to Primary Biliary Cholangitis (PBC): A Pooled Analysis of Phase 2 and Phase 3 Studies” 
Stuart C Gordon, Palak Trivedi, Christopher Bowlus, Michael R Galambos, Aparna Goel, Aliya Gulamhusein, Cynthia Levy, Guy Neff, Carmen Stanca, Douglas Thorburn, Bruce Bacon, Brian Borg, Yvonne Döerffel, Lisa Forman, Bradley Freilich, Liana Gheorghe, María Saraí González-Huezo, Stephen Harrison, Jonathan Huang, Sook-Hyang Jeong, Seung Up Kim, John Lake, Joseph Odin, Won Young Tak, Hillel Tobias, John M. Vierling, Ke Yang, Alexandra (Sasha) Steinberg, Yun-Jung Choi, Charles McWherter, Marlyn J. Mayo

May 22nd 12:30 PM PDT
1351:
3“Treatment With Seladelpar in Patients With Primary Biliary Cholangitis (PBC) and Prior Experience With Obeticholic Acid (OCA) or Fibrates”
Aliya Gulamhusein, Guy Neff, Aparna Goel, Marlyn J. Mayo, Carmen Stanca, Christopher Bowlus, Lisa Forman, Pietro Invernizzi, Frederik Nevens, Ehud Zigmond, Eli Zuckerman, Ke Yang, Yun-Jung Choi, Alexandra (Sasha) Steinberg, Charles McWherter, Kris V. Kowdley

A full list of presentations can be found on https://ddw.org/.

May 12 2022 4:30pm ET

First Quarter 2022 Financial Results Conference Call

May 12, 2022 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID#13728967.

Mar 17 2022 4:30pm ET

Fourth Quarter and Full Year 2021 Financial Results Conference Call

March 17, 2022 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13726915. 

Mar 16 2022 4:40pm ET

Oppenheimer’s 32nd Annual Healthcare Conference

March 16, 2022 at 4:40pm ET

Feb 17 2022 3:00pm ET

11th Annual SVB Leerink Global Healthcare Conference

February 17, 2022 at 3:00pm ET

Dec 2 2021 10:00am ET

Piper Sandler 33rd Annual Virtual Healthcare Conference

December 2, 2021 at 10:00am ET

Nov 30 2021 9:15am ET

Evercore ISI 4th Annual HealthCONx Conference

November 30, 2021 at 9:15am ET

Nov 15 2021 4:30pm ET

Post-AASLD Key Opinion Leader Webinar on Seladelpar for Primary Biliary Cholangitis

November 15, 2021 at 4:30pm ET

Nov 12 2021

The Liver Meeting® 2021

November 12 - November 15, 2021

Virtual

Oral Presentation: November 14th 1:00 PM EST
106: “Long-Term Safety and Efficacy of Seladelpar in Patients with Primary Biliary Cholangitis”

Clinical Poster Presentation: November 12th – 15th
1269: “Efficacy and Safety of Seladelpar in Patients with Compensated Cirrhosis and Evidence of Portal Hypertension due to Primary Biliary Cholangitis”

Preclinical Poster Presentation: November 12th – 15th
1334: “Seladelpar reduces established Liver and Renal Fibrosis in the Non-obese Diabetic Inflammation and Fibrosis (NIF) Mouse Model”

Nov 10 2021 4:30pm ET

Third Quarter 2021 Financial Results Conference Call

November 10, 2021 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13723498.

Nov 8 2021 11:20am ET

Credit Suisse 30th Annual Healthcare Conference

November 8, 2021 at 11:20am ET

Sep 28 2021 3:20PM ET

2021 Cantor Virtual Global Healthcare Conference

September 28, 2021 at 3:20PM ET

Sep 13 2021 7:00AM ET

Fireside Chat: H.C. Wainwright 23rd Annual Global Investment Conference

September 13, 2021 at 7:00AM ET

Sep 9 2021

Citi’s 16th Annual BioPharma Virtual Conference

September 9, 2021

Virtual Meeting

1-on-1 meetings only.

Aug 12 2021 4:30pm ET

Second Quarter 2021 Financial Results Conference Call

August 12, 2021 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13720877.

Jun 28 2021 3:00 pm ET

Piper Sandler “EASL Takeaway Day”

June 28, 2021 at 3:00 pm ET

Please use the access code below to view the Webinar replay.

Access Code: Piper123!

Jun 23 2021

The International Liver Congress™ 2021

June 23 - June 26, 2021

Jun 21 2021 9:20 am ET

Raymond James Human Health Innovation Conference

June 21, 2021 at 9:20 am ET

Jun 17 2021

SVB Leerink CybeRx Series: “Liver Disease Day” Conference

June 17, 2021

Jun 10 2021 8:00 AM PT

2021 Annual Meeting of Stockholders

June 10, 2021 at 8:00 AM PT

Virtual Meeting

Meeting Link: https://www.virtualshareholdermeeting.com/CBAY2021
May 13 2021 4:30pm ET

First Quarter 2021 Financial Results Conference Call

May 13, 2021 at 4:30pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13718350.

Mar 25 2021 4:30 pm ET

Fourth Quarter and Full Year 2020 Financial Results Conference Call

March 25, 2021 at 4:30 pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13715944.

Mar 16 2021 3:50 pm ET

Oppenheimer’s 31st Annual Healthcare Conference

March 16, 2021 at 3:50 pm ET

Mar 12 2021 5:00 pm MT

2021 NASH-TAG Conference

March 12, 2021 at 5:00 pm MT

Mar 9 2021 7:00 am ET

H.C. Wainwright Global Life Sciences Conference

March 9, 2021 at 7:00 am ET

Mar 1 2021 2:10 pm ET

Raymond James 42nd Annual Institutional Investors Conference

March 1, 2021 at 2:10 pm ET

Feb 25 2021 12:00 pm ET

SVB Leerink 10th Annual Global Healthcare Conference

February 25, 2021 at 12:00 pm ET

Track V

Dec 3 2020 9:00 am ET

Piper Sandler 32nd Annual Virtual Healthcare Conference

December 3, 2020 at 9:00 am ET

Dec 1 2020 3:55 pm ET

Evercore ISI 3rd Annual HealthCONx Conference

December 1, 2020 at 3:55 pm ET

Nov 17 2020 1:20 pm ET

Stifel’s 2020 Virtual Healthcare Conference

November 17, 2020 at 1:20 pm ET

Nov 13 2020

The Liver Meeting® 2020

November 13 - November 16, 2020

Nov 5 2020 4:30 pm ET

Third Quarter 2020 Financial Results Conference Call

November 5, 2020 at 4:30 pm ET

Sep 16 2020 10:40 am ET

Cantor Global Healthcare Conference

September 16, 2020 at 10:40 am ET

Sep 14 2020 1:30 pm ET

H.C. Wainwright 22nd Annual Global Healthcare Conference

September 14, 2020 at 1:30 pm ET

Sep 9 2020

Citi’s 15th Annual BioPharma Conference

September 9, 2020

1-on-1 meetings only

Aug 27 2020

Digital International Liver Congress™ 2020 of the European Association for the Study of Liver (EASL)

August 27 - August 29, 2020

Virtual

Aug 10 2020 4:30 pm ET

Second Quarter 2020 Financial Results Conference Call

August 10, 2020 at 4:30 pm ET

To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13706143.

Aug 3 2020 8:00 am ET

CymaBay Therapeutics Data Call

August 3, 2020 at 8:00 am ET

Jun 23 2020 10:00 am PT

2020 Annual Meeting of Stockholders

June 23, 2020 at 10:00 am PT

Virtual Meeting

Meeting Link: www.virtualshareholdermeeting.com/CBAY2020